Skip to main contentSkip to navigation
Sirius Investors
Mirati Therapeutics, Inc.

Mirati Therapeutics, Inc.

MRTX
NASDAQHealthcare

Revenue Analysis - MRTX

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

MRTX Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Product Revenue

0.0% of total revenue

$16.4M

License and Collaboration Revenue

0.0% of total revenue

$0

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 3 records)

Date
License and Collaboration Revenue
Product Revenue
9/30/2023$0$16.4M
6/30/2023$325.0K$13.4M
3/31/2023$876.0K$6.3M

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Growing Segments
Product Revenue+22.7%

Earnings Reports

Want to see how MRTX's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports